By Professor Ric Day

Conference Abstracts

Lu CY; Williams KM; March LM; Bertouch JV; Day RO, 2004, 'Subsided access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?', in Medical Journal of Australia, Australasian Med Publishing Company Ltd, Vol. 181, pp. 457 - 457

Williams KM; Cooper S; Parisis K; Handel M; Day RO, 2001, 'The skin suction blister: A human model of inflammation', in Clinical Pharmacology and Therapeutics, Vol. 69, pp. P61

Williams KM; Mclachlan AJ; Day RO; Pritchard A, 1998, 'Comparative pharmacokinetics of hepatitis B immuno-globulin after intramuscular administration in healthy subjects', in Naunyn - Schmiedebergs Archives of Pharmacology, Springer, New York, NY, USA, pp. 285, presented at Archives of Pharmacology 358, Munich, Germany

Day RO; Mclachlan AJ; Williams KM, 1998, 'Population pharmacokinetics (PK) and pharmacodynamics (PD) of tenoxicam (TN) in patients with rheumatoid arthritis (RA)', in Clinical Pharmacology and Therapeutics, Mosby, St Louis, MO, USA, pp. 168, presented at Clinical and Pharmacology Therapeutics

Williams KM; Turner J; Geisslinger G; Day RO, 1997, 'The suction blister as an in vivo model of inflammation: Interblister variability and preliminary studies of the disposition of methotrexate', in CLINICAL PHARMACOLOGY & THERAPEUTICS, MOSBY-YEAR BOOK INC, Vol. 61, pp. PI93 - PI93, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WJ68400093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

DAY RO; NGUYEN T; WILLIAMS KM, 1993, 'TENOXICAM DOSE CONCENTRATION RESPONSE RELATIONSHIP IN RHEUMATOID-ARTHRITIS (RA)', in CLINICAL PHARMACOLOGY & THERAPEUTICS, MOSBY-YEAR BOOK INC, Vol. 53, pp. 152 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KP26900067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Kumar SS; Graham GG; Smith FC; Furlong TJ; Greenfield JR; Stocker SS; Carland JE; Day RO, 2017, Could metformin be used in patients with advanced chronic kidney disease?, http://dx.doi.org/10.1111/dom.12806

Butterfield RJ; Barratt MJ; Ezard N; Day RO, 2016, Drug checking to improve monitoring of new psychoactive substances in Australia, AUSTRALASIAN MED PUBL CO LTD, http://dx.doi.org/10.5694/mja15.01058

Roberts DM; Chau A; Day RO; Nair P, 2011, Enhanced elimination of phenorbarbital using charcoal haemorperfusion in a patient with severe poisoning, Oxford Univ Press, http://dx.doi.org/10.1093/bja/aer317, http://dx.doi.org/10.1093/bja/aer317

Preprints

Yang Z; Jones C; Billot L; Shan S; Devaux A; Day R; Hamilton M; Koes B; Latimer J; Maher C; McLachlan A; McLachlan H; Webb M; Lin C, 2023, Complier average causal effect (CACE) of oxycodone/naloxone for acute spinal pain: a reanalysis the OPAL trial data ------A Protocol, http://dx.doi.org/10.31219/osf.io/pb647

Westbrook J; Li L; Raban M; Mumford V; Badgery-Parker T; Gates P; Fitzpatrick E; Merchant A; Woods A; Baysari M; McCullagh C; Day R; Gazarian M; Dickinson M; Seaman K; Dalla-Pozza L; Ambler G; Barclay P; Gardo A; O'Brien T; Barbaric D; White L, 2022, Immediate and long-term effects of an electronic medication management system on paediatric prescribing errors: A stepped-wedge cluster randomised controlled trial with one-year follow-up, http://dx.doi.org/10.21203/rs.3.rs-2083575/v1

Nguyen AD; Lind KE; Day RO; Ross D; Raban MZ; Georgiou A; Westbrook JI, 2022, Measuring quality of gout management in residential aged care facilities, http://dx.doi.org/10.21203/rs.3.rs-1387058/v1

Ferdiana A; Liverani M; Khan M; Wulandari LPL; Mashuri YA; Batura N; Wibawa T; Yeung S; Day R; Jan S; Wiseman V; Probandari A, 2021, Community Pharmacies, Drug Stores, and Antibiotic Dispensing in Indonesia: A Qualitative Study, http://dx.doi.org/10.21203/rs.3.rs-514723/v1

Simic M; Harmer AR; Agaliotis M; Nairn L; Bridgett L; March L; Votrubec M; Edmonds J; Woodward M; Day R; Fransen M, 2020, Clinical Risk Factors Associated with Radiographic Osteoarthritis Progression Among People with Knee Pain: A Longitudinal Study, http://dx.doi.org/10.21203/rs.3.rs-67862/v1

Zheng WY; Van Dort B; Marcilly R; Day R; Burke R; Shakib S; Ku Y; Reid-Anderson H; Baysari M, 2020, A Tool for Evaluating Medication Alerting Systems: Development and Initial Assessment (Preprint), http://dx.doi.org/10.2196/preprints.24022

Sandaradura I; Marriott D; Day R; Norris R; Pang E; Stocker S; Lange SR, 2020, Current fluconazole dosing regimens in critically ill adults result in under-exposure during early therapy, http://dx.doi.org/10.22541/au.159769416.61783293

Nguyen AD; Frensham LJ; Wong MXC; Meslin SMM; Martin P; Lau AY; Baysari MT; Day RO, 2018, Patient testing of a mobile health app and review of educational materials designed for gout patient self-management (Preprint), http://dx.doi.org/10.2196/preprints.9811

Other

Nguyen A; Baysari M; Fernon A; Wong M; Stocker S; Day R, 2017, MISSING FEATURE OF HEALTH APP DEVELOPMENT: PATIENTS, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400304400033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page